Open AccessEfficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy
Author(s) -
Wenqiang Yin,
Sicong Ma,
ZhongYi Dong,
Meng Xu,
Wu Mao
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s310331
Subject(s) - atezolizumab , medicine , oncology , biomarker , cohort , lung cancer , immunotherapy , population , metastasis , cancer , randomized controlled trial , pembrolizumab , chemistry , environmental health , biochemistry
Atezolizumab has been used to treat patients with liver metastasis (LM). However, whether atezolizumab is superior to standard of care therapy in an all-comer or selective population with LM is still uncertain.